V-ATPase G3 Inhibitors
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
This histone deacetylase inhibitor could downregulate V-ATPase G3 expression by removing acetyl groups from histones, leading to a condensed chromatin state and reduced transcriptional activity at the V-ATPase G3 gene locus. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor might decrease V-ATPase G3 expression by incorporating into DNA and causing demethylation of gene promoter regions, potentially silencing gene transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
As a histone deacetylase inhibitor, Suberoylanilide Hydroxamic Acid could reduce V-ATPase G3 expression by promoting a closed chromatin confirmation, thereby hindering the access of transcription machinery to the V-ATPase G3 gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
This agent could inhibit V-ATPase G3 expression by the demethylation of CpG islands in the gene's promoter, potentially leading to the repression of its transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Through its role as an activator of retinoic acid receptors, Retinoic Acid might downregulate V-ATPase G3 by binding to response elements in the gene's promoter, altering the transcription of the gene. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
By inhibiting specific tyrosine kinases, Genistein might reduce the expression of V-ATPase G3 by hindering signal transduction pathways that promote the transcription of this gene. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
This compound could decrease V-ATPase G3 expression by directly interacting with transcription factors or through the inhibition of histone acetyltransferases that are necessary for transcriptional activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol might inhibit V-ATPase G3 expression by activating sirtuins that deacetylate histones associated with the gene, leading to transcriptional repression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
By inhibiting histone deacetylation, Sodium Butyrate could lead to a decrease in V-ATPase G3 expression through the induction of a compact chromatin structure that is less permissive for transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
This compound might inhibit expression of V-ATPase G3 by binding to GC-rich sequences in the promoter region of the gene, disrupting the binding of transcription factors necessary for gene activation. | ||||||